Search results :

Rifaximin

More information: STITCH, PubChem (stereo-specific compound: 1) and possibly Wikipedia

ATC Codes: A07AA11, D06AX11

Side effects

Options: Show MedDRA Preferred Terms

Side effect Data for drug Placebo Labels
1 2 3 4 5
Oedema peripheral 15% 8.18% x x x
Dizziness 12.9% 8.18% x x x x x
Fatigue 12.1% 11.3% x x x x x
Ascites 11.4% 9.43% x x x
Flatulence 11.2% 19.7% x x x x x
Headache 9.69% 9.21% x x x x x
Muscle spasms 9.29% 6.92% x x x x x
Abdominal distension 7.86% 7.55% x x x x x
Anaemia 7.86% 3.77% x x x
Abdominal pain 7.19% - 8.57% 8.18% - 10.1% x x x x x
Rectal tenesmus 7.19% 8.77% x x x x x
Cough 7.14% 6.92% x x x
Depression 7.14% 5.03% x x x
Nasopharyngitis 7.14% 6.29% x x x x x
Insomnia 7.14% 6.92% x x x x x
Arthralgia 6.43% 2.52% x x x x x
Back pain 6.43% 6.29% x x x
Dyspnoea 6.43% 4.4% x x x x x
Abdominal pain upper 6.43% 5.03% x x x
Defaecation urgency 5.94% 9.21% x x x x x
Nausea 5.31% - 14.3% 8.33% - 13.2% x x x x x
Constipation 3.75% - 6.43% 3.51% - 6.29% x x x x x
Body temperature increased 3.12% - 6.43% 3.14% - 4.39% x x x x x
Vomiting 2.19% 1.75% x x x x x
Anaphylactic shock postmarketing x x x
Angioedema postmarketing x x x x x
Colitis postmarketing x x x
Infection postmarketing x x x
Dysphagia postmarketing x x x x
Dermatitis exfoliative postmarketing x x x x
Dermatitis atopic postmarketing x
Rash postmarketing, 5% 3.77% x x x x x
Flushing postmarketing x x x x
Hypersensitivity postmarketing x x x x x
Pruritus postmarketing, 9.29% 6.29% x x x x x
Urticaria postmarketing x x x x x
Swelling face postmarketing x x x x
Infestation NOS postmarketing x x x x x
Amnesia x x x
Anorexia x x x x x
Asthenia x x x x x
Mental disorder x x x x x
Bone disorder x x x x x
Cellulitis x x x
Neck pain x x x x x
Chest pain x x x x x
Confusional state x x x
Contusion x x x
Dehydration x x x x x
Diarrhoea x
Dysentery x x x x x
Dysuria x x x x x
Ear pain x x x x x
Epistaxis x x x
Gastrointestinal disorder x x x x x
Gingival disorder x x x x x
Haematuria x x x x x
Haemorrhage x x x
Inguinal hernia x x x x x
Hyperglycaemia x x x
Hyperkalaemia x x x
Hypoaesthesia x x x
Hypoglycaemia x x x
Hyponatraemia x x x
Hypotension x x x
Lymphocytosis x x x x x
Mediastinal disorder x x x x x
Motion sickness x x x x x
Nervous system disorder x x x x x
Neutropenia x x x x x
Pain x x x x x
Pain in extremity x x x
Pharyngitis x x x x x
Pneumonia x x x
Polyuria x x x x x
Proteinuria x x x x x
Respiratory tract infection x x x x x
Rhinitis x x x x x
Sunburn x x x x x
Syncope x x x x x
Tinnitus x x x x x
Tremor x x x
Upper respiratory tract infection x x x x x
Pollakiuria x x x x x
Urinary tract disorder x x x x x
Angiopathy x x x x x
Vertigo x x x
Weight increased x x x
Weight decreased x x x x x
Dry mouth x x x
Monocytosis x x x x x
Migraine x x x x x
Generalised oedema x x x
Aspartate aminotransferase increased x x x x x
Choluria x x x x x
Malnutrition x x x x x
Unspecified disorder of skin and subcutaneous tissue x x x x x
Malaise x x x x x
Myalgia x x x x x
Abdominal pain lower x x x
Abdominal tenderness x x x
Disturbance in attention x x x
Memory impairment x x x
Abnormal dreams x x x x x
Dry throat x x x x x
Upset stomach x x x x x
Sticky skin x x x x x
Influenza like illness x x x
Lip dry x x x x x
Hot flush x x x x x
Sweating increased x x x x x
Blood and lymphatic system disorders x x x x x
Ear and labyrinth disorders x x x x x
Nasal passage irritation x x x x x
Pharyngolaryngeal pain x x x x x
Rhinorrhoea x x x x x
Blood in stool x x x x x
Procedural pain x x x
Ageusia x x x x x

Indications

Information about indications was extracted from the indications and usage sections of the labels.

RIFAXIMIN / XIFAXAN

Side effects:79
Source:FDA

RIFAXIMIN / XIFAXAN

Side effects:82
Source:FDA

RIFAXIMIN

Side effects:117
Source:FDA Structured Product Label

RIFAXIMIN

Side effects:117
Source:FDA Structured Product Label

RIFAXIMIN

Side effects:118
Source:FDA Structured Product Label

Color scheme:

standardalternative

    100%
    75%
    50%
    10%
    frequent (1% to 100%)
    infrequent (0.1% to 1%)
    rare (<0.1%)
    postmarketing
    0%
    no frequency information
    not found on label